Detalles de la búsqueda
1.
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Am J Respir Crit Care Med;
2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626354
2.
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
Histopathology;
84(5): 863-876, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196202
3.
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.
BMC Urol;
24(1): 71, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532370
4.
An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer.
Urol Int;
2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246156
5.
N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
BMC Cancer;
22(1): 943, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050747
6.
Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort.
Urol Int;
106(11): 1150-1157, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158357
7.
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Int J Mol Sci;
23(13)2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35806168
8.
N6 -Methyladenosine (m6 A) readers are dysregulated in renal cell carcinoma.
Mol Carcinog;
60(5): 354-362, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33755994
9.
The N6 -methyladenosine (m6 A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma.
BJU Int;
125(4): 617-624, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31985880
10.
Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
Mol Cancer;
15: 10, 2016 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26831905
11.
Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial Cancer.
Eur Urol Focus;
2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38631991
12.
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer.
Eur Urol;
2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744632
13.
Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
Lung Cancer;
189: 107505, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367405
14.
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.
Cancers (Basel);
16(3)2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339235
15.
Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.
J Cancer Res Clin Oncol;
150(2): 76, 2024 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310601
16.
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
Am J Transl Res;
16(1): 304-313, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322559
17.
Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cureus;
16(1): e53038, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410284
18.
High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma.
Eur J Cancer;
204: 114089, 2024 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38703618
19.
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.
Eur Urol;
85(4): 328-332, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031005
20.
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.
Cancer Res;
84(5): 725-740, 2024 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175774